- Tabernero, J., Grothey, A., Arnold, D., Ducreux, M., O’Dwyer, P. J., Perdicchio, M., . . . Van Cutsem, E. (2021). Exploratory biomarker findings from cohort 2 of MODUL: An adaptable, phase 2, signal-seeking trial of fluoropyrimidine plus bevacizumab +/- atezolizumab maintenance therapy for BRAF(wt) metastatic colorectal cancer. Journal of Clinical Oncology, 39(15). https://doi.org/10.1200/JCO.2021.39.15_suppl.3570 (Meeting abstract)
Exploratory biomarker findings from cohort 2 of MODUL: An adaptable, phase 2, signal-seeking trial of fluoropyrimidine plus bevacizumab +/- atezolizumab maintenance therapy for BRAF(wt) metastatic colorectal cancer
on 17 de gener de 2022
with No hi ha comentaris
Deixa un comentari